• Register
  • Login
  • Subscribe
  • Contact Us

Latest Biosimilar Tenders in USA 2025

USARFP brings you the latest and most relevant Biosimilar tenders in USA, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Biosimilar and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to USARFP, users gain unlimited access to public procurement notices related to Biosimilar. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across USA.

Rituximab and Biosimilars

UST Ref No.:  114758371

Deadline:  11 Mar 2025

Rituximab and Biosimilars

UST Ref No.:  114573412

Deadline:  04 Mar 2025

Rituximab and Biosimilars

UST Ref No.:  113898244

Deadline:  14 Feb 2025

Infliximab Injection 100 Mg/Vial

UST Ref No.:  79539006

Deadline:  28 Mar 2023

Intent to Sole Source: Deliberative Democracy Consultant

UST Ref No.:  77107327

Deadline:  17 Jan 2023

Simcyp Software Licenses Subscription

UST Ref No.:  71463702

Deadline:  08 Oct 2022

Simcyp Software Licenses Subscription

UST Ref No.:  71208266

Deadline:  02 Oct 2022

  Chat with us